Evidence Generation & Value Demonstration

Strengthen Your Value

With today’s focus on the “triple aim”—improving the experience of care, improving the health of populations, and reducing per capita costs of healthcare—demands for high-quality, accurate, and evidence-based information have never been higher. Life science companies are being asked to provide more evidence about product value, including information on effectiveness, costs, and risks of new or existing therapies. With consumers and other industry stakeholders placing an increasing emphasis on data to make their decisions, health plans and providers face a similar challenge to demonstrate value. Avalere develops, implements, and evaluates strategies for improved data collection, integration, and utilization to measure and demonstrate the value of healthcare treatments and services across the patient care continuum.

Team

Kristi Mitchell

Senior Vice President

Contact

KristiMitchell

Kristi Mitchell, Senior Vice President, leads client engagements involving the use of clinical data for strategic decision-making across multiple industries, including life sciences, health plans, and professional societies. In this capacity, she provides strategic guidance for innovative collection and utilization of data, as well as, oversees the diffusion of best practice in quality measurement development, implementation, and evaluation across multiples industries.

Prior to joining Avalere, Kristi worked at the American College of Cardiology (ACC), leading the development of the National Cardiovascular Data Registry, most recently as the Chief Science Officer. Prior to the ACC, she assessed the impact of public health policies, programs, and practices on health outcomes at Battelle Centers for Public Health Policy and Evaluation and at the Institute for Health Policy Studies at the University of California, San Francisco.

Kristi has an AB in Human Biology and Public Policy from Brown University and a MPH in Public Health Policy Administration and Epidemiology from University of Michigan. She sits on the FDA MDEpiNet Interim Advisory Committee and the Pew Trust Future of Medical Device Registry Stakeholder Group.

Eleanor Fitall

Manager

Contact

EleanorFitall

Eleanor Fitall, Manager, provides research and analytical support to Avalere's Evidence Translation and Implementation practice, primarily focusing on data-driven quality improvement efforts in both the public and private sectors.

Prior to joining Avalere, Eleanor interned for Galileo Analytics where she assisted in the analysis of pharmaceutical pipeline development by tracking and conducting studies on upcoming pharmaceutical research. Additionally, while serving as a Research and Marketing Assistant for the Chief Operating Officer, she conducted domestic and international market research and assisted in the development of product launch plans.

Eleanor has a dual BA in International Studies and Sociology from Emory University.

Debbie Lucas

Vice President

Contact

DebbieLucas

Debbie Lucas, Vice President, advises clients on value strategies, market access, and evidence generation. Debbie leads efforts with life sciences companies, professional societies, quality improvement organizations, and healthcare providers related to the strategic collection and use of clinical data to improve patient care with a particular emphasis on electronic health data. Most recently she worked on an initiative that brought together the healthcare provider and EHR communities to design a module focused on childhood obesity to support improvements in healthcare via shared decision-making, care coordination, and self-management.

Prior to joining Avalere, Debbie was the Director of Clinical Quality and Consulting at DocSite (later acquired by Covisint) and spent much of her career at GlaxoSmithKline.

Debbie has a BS in Biology from Baldwin-Wallace College and a MPH in Epidemiology from the University of Michigan. She was a member of the Commonwealth Fund’s Health Care Leaders Opinion Survey Panel.